Pfizer’s Comirnaty, Paxlovid push Q2 sales to new heights

Sales of Pfizer’s COVID-19 vaccine and treatment in the second quarter propelled the pharmaceutical giant to the largest quarterly sales in its history. The coronavirus vaccine Comirnaty brought in $8.85 billion in sales, and the treatment Paxlovid added another $8.12 billion as company revenue totaled $27.74 billion. Pfizer said Thursday that it earned $9.91 billion,…

Read More